Publisher
Springer Nature Singapore
Reference91 articles.
1. Anantharajah A, Mingeot-Leclercq MP, Van Bambeke F. Targeting the type three secretion system in Pseudomonas aeruginosa. Trends Pharmacol Sci. 2016;37(9):734–49.
2. Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P. A diarylquinoline drug active on the ATP synthase of mycobacterium tuberculosis. Science. 2005;307(5707):223–7.
3. Azeredo da Silveira S, Perez A. Improving the fate of severely infected patients: the promise of anti-toxin treatments and superiority trials. Expert review of anti-infective. Therapy. 2017;15(11):973–5.
4. Badari JC, Díaz-Roa A, Teixeira Rocha MM, Mendonça RZ, Silva Junior PI. Patagonin-CRISP: antimicrobial activity and source of antimicrobial molecules in Duvernoy’s gland secretion (Philodryas patagoniensis snake). Front Pharmacol. 2021;2(11):586705.
5. Bailey L, Gylfe Å, Sundin C, Muschiol S, Elofsson M, Nordström P, Henriques-Normark B, Lugert R, Waldenström A, Wolf-Watz H, Bergström S. Small molecule inhibitors of type III secretion in Yersinia block the chlamydia pneumoniae infection cycle. FEBS Lett. 2007;581(4):587–95.